Crystal structure of the NS3 helicase of tick-borne encephalitis virus.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
30 07 2020
Historique:
received: 18 05 2020
accepted: 19 05 2020
pubmed: 9 6 2020
medline: 9 2 2021
entrez: 8 6 2020
Statut: ppublish

Résumé

Tick-borne encephalitis virus (TBEV) is a positive-sense single-stranded RNA virus belonging to the genus Flavivirus in Flaviviridae. It can cause the server infectious diseases named tick-borne encephalitis (TBE), which is characterized by paralysis and epilepsy. However, no effective treatment for TBE has been developed targeting TBEV. The NS3 helicase from TBEV plays an essential role in viral replication, which makes it an important target for drug design. In this study, the crystal structure of TBEV NS3 helicase has been determined to the resolution of 2.14 Å. Subsequent alignment with homologous structures reveals that the NTP binding site and RNA-binding sites are located in motifs Ⅱ and Ⅵ of NS3 and the critical residues for binding are conserved across species in the genus, while the distinct conformation transition implies that the TBEV helicase need a different local rearrangement. This study demonstrates the key atomic-level features of TBEV helicase and provides basis for the design of antiviral drugs targeting TBEV helicase.

Identifiants

pubmed: 32505343
pii: S0006-291X(20)31066-4
doi: 10.1016/j.bbrc.2020.05.138
pii:
doi:

Substances chimiques

NS3 protein, flavivirus 0
Recombinant Fusion Proteins 0
Viral Nonstructural Proteins 0
Serine Endopeptidases EC 3.4.21.-
RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

601-606

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Please note that all Biochemical and Biophysical Research Communications authors are required to report the following potential conflicts of interest with each submission. If applicable to your manuscript, please provide the necessary declaration in the box above.(1) All third-party financial support for the work in the submitted manuscript.(2) All financial relationships with any entities that could be viewed as relevant to the general area of the submitted manuscript.(3) All sources of revenue with relevance to the submitted work who made payments to you, or to your institution on your behalf, in the 36 months prior to submission.(4) Any other interactions with the sponsor of outside of the submitted work should also be reported. (5) Any relevant patents or copyrights (planned, pending, or issued).(6) Any other relationships or affiliations that may be perceived by readers to have influenced, or give the appearance of potentially influencing, what you wrote in the submitted work. As a general guideline, it is usually better to disclose a relationship than not.

Auteurs

Chen Chen (C)

School of Life Sciences, Tianjin University, Tianjin, China. Electronic address: tjuchenchen16@tju.edu.cn.

Xu Han (X)

School of Life Sciences, Tianjin University, Tianjin, China. Electronic address: hanx@tju.edu.cn.

Cheng Chen (C)

School of Life Sciences, Tianjin University, Tianjin, China; Tianjin International Joint Academy of Biotechnology and Medicine, Tianjin, China. Electronic address: chengchen@tju.edu.cn.

Fenghua Wang (F)

School of Life Sciences, Tianjin University, Tianjin, China. Electronic address: wangfh@tju.edu.cn.

Jinhai Huang (J)

School of Life Sciences, Tianjin University, Tianjin, China. Electronic address: jinhaih@tju.edu.cn.

Lei Zhang (L)

School of Life Sciences, Tianjin University, Tianjin, China. Electronic address: zhanglei@tju.edu.cn.

Zefang Wang (Z)

School of Life Sciences, Tianjin University, Tianjin, China; Tianjin International Joint Academy of Biotechnology and Medicine, Tianjin, China. Electronic address: zefangwang@tju.edu.cn.

Haitao Yang (H)

School of Life Sciences, Tianjin University, Tianjin, China; Tianjin International Joint Academy of Biotechnology and Medicine, Tianjin, China. Electronic address: yanght@tju.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH